{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:03:42Z","timestamp":1785423822200,"version":"3.56.0"},"reference-count":29,"publisher":"Society of Nuclear Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,6,26]]},"DOI":"10.2967\/jnumed.126.272574","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:20:15Z","timestamp":1785421215000},"page":"jnumed.126.272574","source":"Crossref","is-referenced-by-count":0,"title":["Tumor and Organ Dose Estimates from\n                    <sup>177<\/sup>\n                    Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the RESIST-PC Phase 2 Trial"],"prefix":"10.2967","author":[{"given":"Zachary","family":"Ells","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karam","family":"Masri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ryhiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sennung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mirando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Tworowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouzbeh","family":"Esfandiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Allen-Auerbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lassmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Eiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang P.","family":"Fendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Delpassand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Czernin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Dahlbom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremie","family":"Calais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"2026073007200737000_jnumed.126.272574v1.1","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"Silver","year":"1997","journal-title":"Clin Cancer Res."},{"key":"2026073007200737000_jnumed.126.272574v1.2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.160382"},{"key":"2026073007200737000_jnumed.126.272574v1.3","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2949-6"},{"key":"2026073007200737000_jnumed.126.272574v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.12.025"},{"key":"2026073007200737000_jnumed.126.272574v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.02.2969"},{"key":"2026073007200737000_jnumed.126.272574v1.6","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2713-y"},{"key":"2026073007200737000_jnumed.126.272574v1.7","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0231"},{"key":"2026073007200737000_jnumed.126.272574v1.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"2026073007200737000_jnumed.126.272574v1.9","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/ph15101292","article-title":"[177Lu]Lu-PSMA-617 (PluvictoTM): The first FDA-approved radiotherapeutical for treatment of prostate cancer","volume":"15","author":"Hennrich","year":"2022","journal-title":"Pharmaceuticals (Basel)."},{"key":"2026073007200737000_jnumed.126.272574v1.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262543"},{"key":"2026073007200737000_jnumed.126.272574v1.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266638"},{"key":"2026073007200737000_jnumed.126.272574v1.12","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.3390\/diagnostics12081926","article-title":"Salivary gland toxicity of PSMA-targeted radioligand therapy with 177Lu-PSMA and combined 225Ac- and 177Lu-labeled PSMA ligands (TANDEM-PRLT) in advanced prostate cancer: a single-center systematic investigation","volume":"12","author":"Langbein","year":"2022","journal-title":"Diagnostics (Basel)."},{"key":"2026073007200737000_jnumed.126.272574v1.13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40658-024-00636-0","article-title":"Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT\/CT","volume":"11","author":"Grob","year":"2024","journal-title":"EJNMMI Phys."},{"key":"2026073007200737000_jnumed.126.272574v1.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267830"},{"key":"2026073007200737000_jnumed.126.272574v1.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.261982"},{"key":"2026073007200737000_jnumed.126.272574v1.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.159012"},{"key":"2026073007200737000_jnumed.126.272574v1.17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40658-021-00397-0","article-title":"A multicentre and multi-national evaluation of the accuracy of quantitative Lu-177 SPECT\/CT imaging performed within the MRTDosimetry project","volume":"8","author":"Tran-Gia","year":"2021","journal-title":"EJNMMI Phys."},{"key":"2026073007200737000_jnumed.126.272574v1.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262245"},{"key":"2026073007200737000_jnumed.126.272574v1.19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262713"},{"key":"2026073007200737000_jnumed.126.272574v1.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265448"},{"key":"2026073007200737000_jnumed.126.272574v1.21","doi-asserted-by":"crossref","first-page":"1483953","DOI":"10.3389\/fonc.2024.1483953","article-title":"Initial clinical experience with [177Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial","volume":"14","author":"Hansen","year":"2025","journal-title":"Front Oncol."},{"key":"2026073007200737000_jnumed.126.272574v1.22","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267452"},{"key":"2026073007200737000_jnumed.126.272574v1.23","first-page":"123","article-title":"Tolerance of normal tissue to therapeutic radiation","volume":"11","author":"Emami","year":"2026","journal-title":"Reports of Radiotherapy and Oncology."},{"key":"2026073007200737000_jnumed.126.272574v1.24","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262749"},{"key":"2026073007200737000_jnumed.126.272574v1.25","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1002\/mp.13178","article-title":"A method for tumor dosimetry based on hybrid planar-SPECT\/CT images and semiautomatic segmentation","volume":"45","author":"Roth","year":"2018","journal-title":"Med Phys."},{"key":"2026073007200737000_jnumed.126.272574v1.26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40658-018-0210-2","article-title":"Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy","volume":"5","author":"Sundl\u00f6v","year":"2018","journal-title":"EJNMMI Phys."},{"key":"2026073007200737000_jnumed.126.272574v1.27","first-page":"113","article-title":"A comparison of 2D and 3D kidney absorbed dose measures in patients receiving 177Lu-DOTATATE","volume":"6","author":"Willowson","year":"2018","journal-title":"Asia Ocean J Nucl Med Biol."},{"key":"2026073007200737000_jnumed.126.272574v1.28","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1422-4"},{"key":"2026073007200737000_jnumed.126.272574v1.29","doi-asserted-by":"crossref","first-page":"v329","DOI":"10.1093\/annonc\/mdz248.006","article-title":"Preliminary results of a phase I\/II dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC)","volume":"30","author":"Tagawa","year":"2019","journal-title":"Ann Oncol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.126.272574","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:20:18Z","timestamp":1785421218000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.126.272574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":29,"alternative-id":["10.2967\/jnumed.126.272574"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.126.272574","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]}}}